|
|
||||||||
Donner Laboratory and Lawrence Berkeley Laboratory, University of California, Berkeley, California
Correspondence: For reprints contact: Yukio Yano, Donner Laboratory, Lawrence Berkeley Laboratory, University of California, Berkeley, Calif. 94720.
ABSTRACT
Technetium-99m was complexed with Sn-EHDP to provide a bone scanning agent that makes available the superior scanning characteristics of 99mTc. The concentrations of Sn(II) and EHDP as well as the order of addition of the reagents influence the in vivo distribution of the 99mTc-Sn-EHDP. In vitro stability was dependent upon having oxygen-free environment for the preparation. Animal studies and human studies now in progress indicate that 99mTc-Sn-EHDP will be extremely useful as a bone scanning agent because of the high ratio of bone-to-soft tissue uptake, high lesion-to-normal-bone uptake, rapid disappearance from blood and soft tissues, and low radiation dose to the patient.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |